Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed. This is a minor metadata update with no impact on study details.
    Difference
    0.0%
    Check dated 2025-12-01T17:37:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications section wording updated to specify automatic filling from PubMed and the new revision tag v3.3.1. The previous wording about PubMed-derived publications and the older v3.2.0 revision has been removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:39:40.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page, and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:53:54.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Participating Locations section has been updated to reflect changes in sites across multiple states and countries. This may affect where patients can enroll and access trial information.
    Difference
    0.2%
    Check dated 2025-11-03T01:16:19.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:23:32.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.
    Difference
    0.2%
    Check dated 2025-09-28T03:19:45.000Z thumbnail image

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.